Inicio>>Signaling Pathways>> Others>>Fabomotizole hydrochloride (CM346 hydrochloride)

Fabomotizole hydrochloride (CM346 hydrochloride) (Synonyms: SM-346)

Catalog No.GC30903

El clorhidrato de fabomotizol (clorhidrato de CM346) (clorhidrato de CM346) es un fÁrmaco ansiolÍtico.

Products are for research use only. Not for human use. We do not sell to patients.

Fabomotizole hydrochloride (CM346 hydrochloride) Chemical Structure

Cas No.: 173352-39-1

Tamaño Precio Disponibilidad Cantidad
10mM (in 1mL DMSO)
180,00 $
Disponible
5mg
198,00 $
Disponible
10mg
352,00 $
Disponible
50mg
1.251,00 $
Disponible
100mg
1.663,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Fabomotizole Hcl (CM346 Hcl) is an anxiolytic drug; produces anxiolytic and neuroprotective effects without any sedative or muscle relaxant actions.IC50 value:Target: anxiolytic agent Afobazole's mechanism of action remains poorly defined however, with GABAergic, NGF and BDNF release promoting, MT1 receptor antagonism, MT3 receptor antagonism, and sigma agonism suggested as potential mechanisms. Afobazole was shown to inhibit MAO-A reversibly and there might be also some involvement with serotonin receptors. Afobazole has found little clinical use outside of Russia and has not been evaluated by the FDA.

[1]. Afobazole, From Wikipedia

Reseñas

Review for Fabomotizole hydrochloride (CM346 hydrochloride)

Average Rating: 5 ★★★★★ (Based on Reviews and 5 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Fabomotizole hydrochloride (CM346 hydrochloride)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.